ENvue Medical, Inc. (FEED)
About ENvue Medical, Inc.
ENvue Medical Inc develops medical devices for enhanced navigation in clinical procedures. The company provides personalized navigation technology to assist clinicians in placing feeding tubes safely and efficiently. Its ENvue system uses smart feeding tubes with sensors, body mapping, and continuous visual guidance to confirm accurate positioning and reduce complications like lung misplacement. The company conducted the business through two primary operating segments: NanoVibronix and ENvue. The firm generates the majority of its revenue from NanoVibronix, which derives revenues from selling its products directly to patients as well as through distributor agreements. ENvue derives revenues from selling its Systems and Nasoenteral tubes.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $2.6M
- Net income
- -$18.2M
- Total assets
- $41.1M
- Market cap
- $5.3M
- Gross margin
- 6.0%
- Operating margin
- -896.6%
- Net margin
- -712.3%
Source: SEC EDGAR · updated Jun 7, 2026
Financial statements
Income statement
- Revenue
- $2.6M
- Cost of revenue
- $2.4M
- Gross profit
- $153.0K
- Operating expenses
- $23.0M
- Operating income
- -$22.9M
- Income tax
- -$307.0K
- Net income
- -$18.2M
- EPS (basic)
- $-26.69
- EPS (diluted)
- $-26.69
Balance sheet
- Total assets
- $41.1M
- Current assets
- $7.3M
- Total liabilities
- $7.6M
- Current liabilities
- $6.7M
- Shareholders’ equity
- $33.5M
Cash flow
- Operating cash flow
- -$9.4M
- Investing cash flow
- $88.0K
- Financing cash flow
- $12.8M
- Net cash flow
- $3.5M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $5.3M
- EPS (diluted)
- $-26.69
- Shares outstanding
- 13.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 24, 2015
ENvue Medical, Inc. (FEED) Stock Price
- Reported a net loss of $18.2M in FY2025.
- Gross margin of 6.0%, net margin -712.3%.
- Trading 91% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ENvue Medical, Inc..
Write a review
News about ENvue Medical, Inc.
News & sentiment via Polygon.io
ENvue Medical, Inc.: frequently asked questions
Is ENvue Medical, Inc. an American company?
ENvue Medical, Inc. is a US-based company headquartered in Tyler, Texas, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is ENvue Medical, Inc. headquartered?
ENvue Medical, Inc. is headquartered in Tyler, Texas, United States.
Is ENvue Medical, Inc. publicly traded?
Yes — ENvue Medical, Inc. is a publicly traded company. Its stock trades under the ticker symbol FEED on the NASDAQ.
What does ENvue Medical, Inc. do?
ENvue Medical, Inc. is an American Medical Devices company in the Health & Beauty sector.
